Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study

BACKGROUND: The programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) pathway inhibits the activation of T cells and plays a crucial role in the negative regulation of cellular and humoral immune responses. Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoid malignancy...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Chin J Cancer
Päätekijät: Hu, Li-Yang, Xu, Xiao-Lu, Rao, Hui-Lan, Chen, Jie, Lai, Ren-Chun, Huang, Hui-Qiang, Jiang, Wen-Qi, Lin, Tong-Yu, Xia, Zhong-Jun, Cai, Qing-Qing
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2017
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5732416/
https://ncbi.nlm.nih.gov/pubmed/29246182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-017-0262-z
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia